A number of pharmaceutical industry figures have called on the government to consider introducing single-digit fixed rebates into the next iteration of the voluntary drug pricing and access scheme (VPAS), which will begin in 2024.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?